Atlas Trials

The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness

Clinical trial NCT02423512 · COMPLETED

Trial details

NCT number
NCT02423512
Sponsor
Icahn School of Medicine at Mount Sinai
Status
COMPLETED
Study type
OBSERVATIONAL
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Start date
2015-06-01
Primary completion
2017-06-13
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.